Status:
UNKNOWN
Achillestendinopathy Treated With Proximal Medial Gastrocnemius Recession
Lead Sponsor:
Ostfold Hospital Trust
Collaborating Sponsors:
Oslo University Hospital
Conditions:
Achilles Tendinopathy
Chronic Pain
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a prospective cohort study that will follow 60 patients treated with Proximal Medial Gastrocnemius Recession for Chronic Mid-Portion Achilles Tendinopathy for 5 years postoperatively.
Detailed Description
Mid Portion Achilles Tendinopathy is a condition that usually resolves by itself without any kind of intervention. If the condition becomes chronic, eccentric training guided by a physical therapist s...
Eligibility Criteria
Inclusion criteria:
- Age 18-75 years.
- Diagnosis CMPAT verified clinically by orthopedic surgeon. Symptoms must include mid-portion pain in the Achilles, swelling and reduced tolerance for weightbearing.
- Verified diagnosis with MRI findings representing pathologic processes of tendon degeneration and repair (13). MRI no older than 12 months.
- Duration of symptoms must be at least 12 months.
- Isolated gastrocnemius tightness must be verified with the Silfverskiölds test before inclusion. The Silfverskiöld test is considered positive if ankle dorsiflexion is restricted to 5 degrees or less with the knee extended, and there is an increase of ankle dorsiflexion of at least 10 degrees when flexing the knee.
- At least three months of conventional physical therapy with eccentric training must have been tried without providing relief of symptoms.
Exclusion criteria:
- Previous history of complete Achilles tendon rupture.
- Other combined pathologies in the Achilles tendon of calf (Sequela from trauma, infections, cancer etc.).
- Insertional Achilles tendinopathy.
- Previously undergone surgery in affected tendon.
- Patients with severe talocrural pathology or serious malalignment of foot and ankle.
- Severely reduced peripheral circulation.
- History of alcoholism, drug abuse, psychological or other emotional problems likely to jeopardize informed consent.
- Patients with a contraindication/non-compliance for MRI examination.
- History of allergic reaction/anaphylactic reaction to local anesthetics.
- Not able to read and/or speak a Scandinavian language or English adequately.
- Other serious comorbidity that makes surgery unadvisable.
Key Trial Info
Start Date :
December 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05179551
Start Date
December 31 2021
End Date
December 31 2025
Last Update
March 8 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital, Orthopedic Department Ullevål
Oslo, Norway, 1714
2
Østfold Hospital Trust
Sarpsborg, Østfold fylke, Norway, 1714